Fecal Calprotectin Test Market to Grow with a CAGR of 6.85% through 2029
Expansion in Healthcare Expenditure is expected to
drive the Global Fecal Calprotectin Test Market growth in the forecast period,
2025-2029.
According to TechSci Research report, “Fecal Calprotectin Test Market - Global Industry Size, Share,
Trends, Competition Forecast & Opportunities, 2029F”, the Global
Fecal Calprotectin Test Market stood at USD 275.65 Million in 2023 and is
anticipated to grow with a CAGR of 6.85% through 2029. Rising
healthcare budgets and investments in infrastructure are improving the
availability and accessibility of advanced diagnostic tools, including fecal
calprotectin tests. Increased funding supports the development, acquisition,
and implementation of innovative diagnostic solutions. According to an OECD
report, health spending from public sources is expected to grow at twice the
rate of government revenues (2.6% versus 1.3% on average across OECD
countries). This trend, combined with the need for investments to strengthen
health systems for future resilience, could result in health spending reaching
up to 11.8% of GDP by 2040. Higher healthcare expenditure facilitates the
broader distribution and accessibility of fecal calprotectin tests across
various healthcare settings, addressing the growing demand for reliable
diagnostic tools in both developed and emerging markets. Increased funding also
supports research and development efforts, driving innovations that enhance the
accuracy and effectiveness of fecal calprotectin tests.
Expanded healthcare spending helps integrate fecal
calprotectin tests into routine clinical practice, standardizing their use for
diagnosing and monitoring chronic gastrointestinal conditions. This funding
enables the creation of specialized diagnostic and treatment programs,
particularly for gastrointestinal health, further supporting the adoption of
fecal calprotectin tests. Additionally, as health insurance coverage expands,
more patients gain access to advanced diagnostic tools like fecal calprotectin
tests, making them more widely available.
Browse over XX market data Figures spread
through XX Pages and an in-depth TOC on " Global Fecal Calprotectin Test Market”
Global Fecal Calprotectin Test Market is segmented
into assay type, indication, end user, regional distribution, and company.
Based on Assay Type, Quantitative
Immune-Chromatography emerged
as the fastest growing segment in the global market for Fecal Calprotectin Test
during the forecast period. This
method provides rapid results, often within minutes, which is essential for
making timely decisions in point-of-care settings. It is simpler to perform
than more complex methods like ELISA, requiring less specialized equipment and
training. This accessibility makes it suitable for a wide range of healthcare
environments, including primary and urgent care facilities. Quantitative
immune-chromatography tests are designed to be user-friendly and portable,
allowing use outside traditional laboratory settings and supporting their
widespread adoption. They are also more cost-effective compared to other
diagnostic methods, which is advantageous for both healthcare providers and
patients, especially in areas with limited resources. The quick results and
ease of use make these tests ideal for routine clinical practice, where fast
diagnostic information is crucial for effective patient care.
Based on Region, the Asia Pacific region is expected
to be fastest growing region during the forecast period. The prevalence
of inflammatory bowel disease (IBD) and other gastrointestinal disorders is
rising across Asia-Pacific countries. According to The Lancet, urbanization,
industrialization, and related lifestyle changes are contributing to a growing
incidence of IBD in the region, with projections suggesting that the disease
burden may soon surpass that of high-income countries. This expanding patient
population is driving increased demand for effective diagnostic tools, such as
fecal calprotectin tests. Countries in the Asia-Pacific region, including India
and Japan, are enhancing their healthcare budgets to improve access and
services. This increase in funding supports the adoption and use of advanced
diagnostic technologies. Additionally, heightened efforts in healthcare
education and awareness are leading to a better understanding of
gastrointestinal health and the benefits of fecal calprotectin tests, thereby
boosting adoption rates. Technological advancements are significantly improving
the accuracy, sensitivity, and specificity of fecal calprotectin tests.
Innovations, such as enhanced assay methods and digital integration, are making
tests more effective and user-friendly. In 2024, the Australia-based non-profit
organization Crohn’s Colitis Cure (CCCure) introduced a subscription-based
registry providing access to a comprehensive database of patient-reported and
clinical data on IBD, including Crohn’s disease and ulcerative colitis. This
registry is one of the largest of its kind, offering valuable real-time insights.
The growing middle class in countries like China and India is gaining better
access to healthcare services and diagnostic tools, supporting the market
growth for fecal calprotectin tests as more people seek advanced healthcare
solutions.
Major companies operating in Global Fecal Calprotectin Test Market are:
- Thermo Fisher
Scientific Inc.
- Bio-Rad
Laboratories, Inc.
- F. Hoffmann-La
Roche Ltd
- Boditech Med
Inc.
- Abbexa Ltd.
- Elabscience
Bionovation Inc.
- Epitope
Diagnostics, Inc.
- R-Biopharm AG
- Sentinel Ch
S.p.A.
- LifeSpan
BioSciences, Inc
Download Free Sample Report
Customers can also request for 10%
free customization on this report
“As both patients and healthcare providers
increasingly acknowledge the advantages of early and non-invasive diagnostics,
the demand for fecal calprotectin tests especially for tracking
gastrointestinal conditions such as celiac disease is growing. Advances in
testing technology are enhancing both accuracy and accessibility, establishing
these tests as essential for effective celiac disease management. This trend
underscores a larger shift toward more efficient and patient-centric diagnostic
solutions within the healthcare industry.”, said Mr. Karan Chechi, Research
Director of TechSci Research, a research-based management consulting firm.
“Fecal Calprotectin Test Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Assay Type (Enzyme Linked Immunosorbent Assay (ELISA), Enzyme Fluoroimmunoassay, and Quantitative Immune-Chromatography), By Indication (Inflammatory Bowel Disease (IBD) Diagnosis, Colorectal Cancer, Celiac Disease, and others), By End User (Hospitals, Diagnostic Laboratories, Academic and Research Institutes, and others), By Region and Competition, 2019-2029F”, has evaluated
the future growth potential of Global Fecal Calprotectin Test Market and provides statistics &
information on market size, structure, and future market growth. The report
intends to provide cutting-edge market intelligence and help decision makers
take sound investment decisions. Besides, the report also identifies and
analyzes the emerging trends along with essential drivers, challenges, and
opportunities in Global Fecal Calprotectin Test Market.
Contact
TechSci Research
LLC
420 Lexington
Avenue, Suite 300,
New York, United
States- 10170
Tel: +1-332-258-6602
Email: [email protected]
Website: www.techsciresearch.com